In this presentation you find a financial analysis of ThromboGenics presented by Glenn De Koeijer

1. Financial Anaysis
By Glenn De Koeijer
2FV01

2. Overview
• Introduction
• Stock price analysis
• Result per share analysis
• Revenue & income statement
• Prediction income statement
• Conclusion
• Sources

3. Introduction
• Leuven (Belgium)
• New Jersey (U.S.)
• Dublin (Ireland)
• +/- 130employees
• Ophthalmic medicines

4. Stock price graphic
(1year)

5. Stock price graphic since
31/12/2007

6. Result per share

7. Revenu & income
statement

8. Prediction income
statement

9. Conclusion
• Signs of great future
• Annual results not good
• Stock price climbed
• 2012 peak
• Future ensured

10. Sources
• http://www.euroinvestor.com/exchanges/euronext-
brussels/thrombogenics/580079
• http://nl.wikipedia.org/wiki/ThromboGenics
• http://thrombogenics.com/company-overview/
• http://thrombogenics.com/wp-content/uploads/2011/03/TG-AR2011-
EN_financial4.pdf
• http://www.slideshare.net/Lien2AF3/financial-analysis-of-the-
cocacola-company
• http://www.tijd.be/beurzen/ThromboGenics.60191463
• http://markets.ft.com/research/Markets/Tearsheets/Financials?s=THR
:BRU
• http://www.4-traders.com/THROMBOGENICS-29715/financials/

11. Thank you for
watching
Any questions 
glendkoe@student.arteveldehs.be